Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, with an error header visible. This indicates that the study record is currently inaccessible and the content is replaced by an access-denied message.SummaryDifference20%

- Check43 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing Revision: v3.6.5. This reflects a minor software update to the page rather than changes to the trial details.SummaryDifference0.1%

- Check57 days agoChange DetectedA new Study Protocol and Statistical Analysis Plan PDF was added to the Study Documents section, provided by the University of Pittsburgh; the file size is 0.73 MB.SummaryDifference59%

- Check64 days agoChange Detected- The page revision in the footer updated from v3.6.4 to v3.6.5. This reflects a new build/version of the page without changing substantive content.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision label now shows v3.6.4, indicating a new site version has been deployed.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a newer page revision rather than a change to study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.